Pharmaceuticals and Healthcare Reports Mycobacterium tuberculosis ESAT 6 Protein EsxA Click to read
  • Comments

Pharmaceuticals and Healthcare Reports

Mycobacterium tuberculosis ESAT 6 Protein EsxA

Published on in “Health & Fitness, Health & Fitness”, language — English. 3 pages.
Global Markets Direct's, 'Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Pipeline Review, H2 2016', provides in depth analysis on Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) targeted pipeline therapeutics. More
Global Markets Direct's, 'Allergic Asthma - Pipeline Review, H2 2016', provides an overview of the Allergic Asthma pipeline landscape. More
Subscribe for FREE

Other issues of “Pharmaceuticals and Healthcare Reports”

View all issues